ORASURE TECHNOLOGIES, INC APIC, Share-based Payment Arrangement, Increase for Cost Recognition
ORASURE TECHNOLOGIES, INC (OSUR) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-07
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $2.29M, a 27.74% decline year-over-year.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $2.77M, a 3.01% increase year-over-year.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $2.83M, a 1.84% decline year-over-year.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $3.17M, a 4.73% decline year-over-year.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $10.15M, a 14.87% decline from fiscal 2024.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $11.92M, a 11.10% increase from fiscal 2023.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $10.73M, a 7.68% decline from fiscal 2022.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $11.62M, a 48.87% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.29M 10-Q · filed 2026-08-07 | $5.05M derived: sum of 2 quarters · filed 2026-08-07 | |||
| 2026-03-31 | $2.77M 10-Q · filed 2026-08-07 | ||||
| 2025-12-31 | $10.15M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $2.83M 10-Q · filed 2025-11-05 | $6.00M derived: sum of 2 quarters · filed 2026-08-07 | $8.69M derived: sum of 3 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $3.17M 10-Q · filed 2026-08-07 | $5.85M derived: sum of 2 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $2.69M 10-Q · filed 2026-08-07 | ||||
| 2024-12-31 | $11.92M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $2.89M 10-Q · filed 2025-11-05 | $6.21M derived: sum of 2 quarters · filed 2025-11-05 | $9.18M derived: sum of 3 quarters · filed 2025-11-05 | ||
| 2024-06-30 | $3.32M 10-Q · filed 2025-11-05 | $6.29M derived: sum of 2 quarters · filed 2025-11-05 | |||
| 2024-03-31 | $2.97M 10-Q · filed 2025-11-05 | ||||
| 2023-12-31 | $10.73M 10-K · filed 2026-03-09 | ||||
| 2023-09-30 | $2.59M 10-Q · filed 2024-11-06 | $4.95M derived: sum of 2 quarters · filed 2024-11-06 | $7.60M derived: sum of 3 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $2.36M 10-Q · filed 2024-11-06 | $5.01M derived: sum of 2 quarters · filed 2024-11-06 | |||
| 2023-03-31 | $2.65M 10-Q · filed 2024-11-06 | ||||
| 2022-12-31 | $11.62M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | $2.30M 10-Q · filed 2023-11-08 | $5.58M derived: sum of 2 quarters · filed 2023-11-08 | $8.23M derived: sum of 3 quarters · filed 2024-05-09 | ||
| 2022-06-30 | $3.28M 10-Q · filed 2023-11-08 | $5.93M derived: sum of 2 quarters · filed 2024-05-09 | |||
| 2022-03-31 | $2.65M 10-Q · filed 2024-05-09 | $3.52M 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $7.81M 10-K · filed 2024-03-11 | ||||
| 2021-09-30 | $2.22M 10-Q · filed 2022-11-08 | $3.69M derived: sum of 2 quarters · filed 2022-11-08 | $5.16M derived: sum of 3 quarters · filed 2022-11-08 | ||
| 2021-06-30 | $1.47M 10-Q · filed 2022-11-08 | $2.94M derived: sum of 2 quarters · filed 2022-11-08 | |||
| 2021-03-31 | $1.46M 10-Q · filed 2022-11-08 | ||||
| 2020-12-31 | $7.14M 10-K · filed 2023-03-03 | ||||
| 2020-09-30 | $1.86M 10-Q · filed 2021-11-04 | $4.54M derived: sum of 2 quarters · filed 2021-11-04 | $5.91M derived: sum of 3 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $2.67M 10-Q · filed 2021-11-04 | $4.05M derived: sum of 2 quarters · filed 2021-11-04 | |||
| 2020-03-31 | $1.38M 10-Q · filed 2021-11-04 | ||||
| 2019-12-31 | $4.06M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $1.44M 10-Q · filed 2020-11-05 | $2.05M derived: sum of 2 quarters · filed 2020-11-05 | $3.28M derived: sum of 3 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $616.00K 10-Q · filed 2020-11-05 | $1.85M derived: sum of 2 quarters · filed 2020-11-05 | |||
| 2019-03-31 | $1.23M 10-Q · filed 2020-11-05 | ||||
| 2018-12-31 | $15.24M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |